Brind.

Quest Diagnostics is trading in pre-market hours on the NYSE, with Dan Edelstein involved as VP and General Manager for Haystack Oncology.

1 report, 1 independent Updated Jun 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Quest Diagnostics New York Stock Exchange

Keep exploring

The entities involved

Quest Diagnostics
medical research company
- Market share and investment focus comparison between Quest Diagnostics and GeneDx Holdings Corp. is underway.Mon 12:54
- Quest Diagnostics made required filings with the Securities and Exchange Commission regarding share holdings on June 18, 2026.Mon 10:44
New York Stock Exchange
American stock exchange
- The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
- A company managing Bitcoin treasury services was listed on the New York Stock Exchange.Mon 16:08

Coverage

Newest first; wire copies grouped

Jun 24finanznachrichten.de